文献速递其他结缔组织病

简版负面评价恐惧量表三个版本在系统性硬化症患者中的信效度:硬皮病以患者为中心的干预网络队列研究

Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2018-01-01

研究纳入硬皮病以患者为中心的干预网络队列中1010例系统性硬化症患者,评估简版负面评价恐惧量表三个版本的结构效度、内部一致性信度及聚合与区分效度。验证性因子分析显示三版本单因子模型拟合可接受,Cronbach's α均显示极好内部一致性,三个版本与社交焦虑、体象态度、抑郁、年龄及教育程度的相关性相当。作者认为BFNE-S量表更广泛被研究且已在更多人群中获强效度数据,推荐用于系统性硬化症患者负面评价恐惧的评估。

要点

  • 在1010例系统性硬化症患者中,BFNE-II、BFNE-S、BFNE-8的单因子模型拟合均可接受。
  • 三版本Cronbach's α分别为BFNE-II=0.98、BFNE-S=0.97、BFNE-8=0.96,内部一致性极好。
  • 12条目BFNE-II较8条目版本未改善测量性能,作者推荐BFNE-S用于系统性硬化症患者。

核心结论

  • 三个版本的BFNE均获得心理测量学支持,但较长的12条目BFNE-II相比两个较短8条目版本未改善测量性能。
  • 两个8条目版本中BFNE-S被更广泛研究且已在更多人群中获强效度数据,作者推荐BFNE-S用于评估系统性硬化症患者的负面评价恐惧。

研究设计与样本

  • 研究纳入硬皮病以患者为中心的干预网络队列中1010例系统性硬化症患者。
  • 采用多组验证性因子分析评估结构效度,Cronbach's α评估内部一致性信度,Pearson积矩相关评估聚合效度与区分效度。

主要发现

  • 验证性因子分析显示12条目BFNE-II、8条目BFNE-S和8条目BFNE-8的单因子模型拟合均可接受。
  • 所有Cronbach's α均显示极好内部一致性信度:BFNE-II=0.98,BFNE-S=0.97,BFNE-8=0.96。
  • 所有版本与社交焦虑、体象态度、抑郁、年龄及教育程度测量指标的相关性相当。

关键数值与推荐

  • BFNE-II的Cronbach's α=0.98,BFNE-S的Cronbach's α=0.97,BFNE-8的Cronbach's α=0.96。
  • 12条目BFNE-II相比8条目BFNE-S和BFNE-8未改善测量性能。
  • BFNE-S被更广泛研究且已在更多人群中获强效度数据,作者推荐用于系统性硬化症患者。

临床怎么用

  • 作者推荐采用BFNE-S评估系统性硬化症患者的负面评价恐惧。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fear of negative evaluation is a common concern among individuals with visible differences but has received limited attention in systemic sclerosis (SSc), which can involve substantial changes to appearance. The Brief Fear of Negative Evaluation Scale (BFNE) was specifically designed to evaluate fear of negative evaluation. There are currently 3 versions of the BFNE with strong demonstrated measurement properties: two 8-item versions (BFNE-S, BFNE-8) and one 12-item version (BFNE-II). The present study evaluated these versions in SSc, and identified the most appropriate version for use among SSc patients. METHODS: Participants were 1,010 patients with SSc enrolled in the Scleroderma Patient-Centered Intervention Network cohort. Multiple group confirmatory factor analysis, Cronbach's alpha, and Pearson's product-moment correlations were used to evaluate structural validity, internal consistency reliability, and convergent and divergent validity, respectively. RESULTS: Confirmatory factor analysis demonstrated that 1-factor models fit acceptably well for the 12-item BFNE-II, the 8-item BFNE-S, and the 8-item BFNE-8. Additionally, all Cronbach's alphas demonstrated excellent internal consistency reliability (BFNE-II = 0.98, BFNE-S = 0.97, BFNE-8 = 0.96), and all versions had comparable associations with measures of social anxiety, body-related attitudes, depression, age, and education. CONCLUSION: Psychometric support was found for all 3 versions of the BFNE, although the longer 12-item BFNE-II did not improve measurement compared to the shorter 8-item versions (BFNE-S and BFNE-8). Of these 2, the BFNE-S has been more widely studied, with strong validity data in a greater number of populations. Therefore, the BFNE-S is recommended to assess fear of negative evaluation among patients with SSc.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Fox RS, Kwakkenbos L, Carrier ME, et al. Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study. Arthritis Care Res (Hoboken). 2018. PMID: 29409146. doi:10.1002/acr.23532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。